Back to search
FDAFDA · Food and drugs·Recall number D-837-2013

Reumofan Plus, 30-count tablets per bottle, distriubted by Reumofan Plus USA, LLC and Reumofan USA, LLC, Springfield, PA, and manufactured by Riger Natural S.A., Mexico.

Published August 14, 2013 · Recall initiated: January 4, 2013

Summary

FDA records drug Class I recall D-837-2013, published August 14, 2013 and initiated January 4, 2013. Recalling firm: Reumofan Plus USA; Status: Terminated; Reported quantity: 586 bottles; Lot: Lot #: 99515, Exp 09/2016. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed without an approved NDA/ANDA: Product may contain undeclared active pharmaceutical ingredients Diclofenac Sodium, Dexamethasone, and Methocarbamol.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Reumofan Plus USA
Distributor
Nationwide through internet sales.
Lot
Lot #: 99515, Exp 09/2016
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Reumofan Plus, 30-count tablets per bottle, distriubted by Reumofan Plus USA, LLC and Reumofan USA, LLC, Springfield, PA, and manufactured by Riger Natural S.A., Mexico. recalled?

Yes. FDA published recall D-837-2013 on August 14, 2013. Reported hazard: Marketed without an approved NDA/ANDA: Product may contain undeclared active pharmaceutical ingredients Diclofenac Sodium, Dexamethasone, and Methocarbamol.

What should I do if I have this product?

Voluntary: Firm initiated · Letter